{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:12:30Z","timestamp":1784013150281,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00277-009-0720-z","type":"journal-article","created":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T10:22:18Z","timestamp":1236594138000},"page":"1069-1077","source":"Crossref","is-referenced-by-count":9,"title":["Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy"],"prefix":"10.1007","volume":"88","author":[{"given":"Yenan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"720_CR1","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","volume":"91","author":"S Faderl","year":"1998","unstructured":"Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91:3995\u20134019","journal-title":"Blood"},{"key":"720_CR2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.seminhematol.2006.01.007","volume":"43","author":"RA Larson","year":"2006","unstructured":"Larson RA (2006) Management of acute lymphoblastic leukemia in older patients. Semin Hematol 43:126\u2013133. doi: 10.1053\/j.seminhematol.2006.01.007","journal-title":"Semin Hematol"},{"key":"720_CR3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x","volume":"95","author":"H Rieder","year":"1996","unstructured":"Rieder H, Ludwig W-D, Gassmann W et al (1996) Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Br J Haematol 95:678\u2013691. doi: 10.1046\/j.1365-2141.1996.d01-1968.x","journal-title":"Br J Haematol"},{"key":"720_CR4","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135","volume":"87","author":"Groupe Francais de Cytogenetique Hematologique","year":"1996","unstructured":"Groupe Francais de Cytogenetique Hematologique (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique. Blood 87:3135\u20133142","journal-title":"Blood"},{"key":"720_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V76.3.489.489","volume":"76","author":"WM Crist","year":"1990","unstructured":"Crist WM, Carroll AJ, Jackson JF et al (1990) Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489\u2013494","journal-title":"Blood"},{"key":"720_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01715353","volume":"64","author":"G Gotz","year":"1992","unstructured":"Gotz G, Weh H-J, Walter TA et al (1992) Clinical and prognostic significance of Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 64:97\u2013100. doi: 10.1007\/BF01715353","journal-title":"Ann Hematol"},{"key":"720_CR7","first-page":"953","volume":"8","author":"B Johansson","year":"1994","unstructured":"Johansson B, Mertens F, Mitelman F (1994) Secondary chromosomal abnormalities in acute leukemia. Leukemia 8:953\u2013962","journal-title":"Leukemia"},{"issue":"4","key":"720_CR8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.leu.2403324","volume":"18","author":"NA Heerema","year":"2004","unstructured":"Heerema NA, Harbott J, Galimberti S et al (2004) Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia 18(4):693\u2013702. doi: 10.1038\/sj.leu.2403324","journal-title":"Leukemia"},{"issue":"3","key":"720_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04736.x","volume":"124","author":"M Wetzler","year":"2004","unstructured":"Wetzler M, Dodge RK, Mr\u00f3zek K et al (2004) Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol 124(3):275\u2013288. doi: 10.1046\/j.1365-2141.2003.04736.x","journal-title":"Br J Haematol"},{"issue":"2","key":"720_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3324\/haematol.11891","volume":"93","author":"M Yanada","year":"2008","unstructured":"Yanada M, Takeuchi J, Sugiura I et al (2008) Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Haematologica 93(2):287\u2013290. doi: 10.3324\/haematol.11891","journal-title":"Haematologica"},{"issue":"4","key":"720_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.10227","volume":"71","author":"BS Ko","year":"2002","unstructured":"Ko BS, Tang JL, Lee FY et al (2002) Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome\/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol 71(4):291\u2013299. doi: 10.1002\/ajh.10227","journal-title":"Am J Hematol"},{"issue":"8","key":"720_CR12","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109(8):3189\u20133197. doi: 10.1182\/blood-2006-10-051912","journal-title":"Blood"},{"key":"720_CR13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","volume":"10","author":"R Trueworthy","year":"1992","unstructured":"Trueworthy R, Shuster J, Look M et al (1992) Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10:606\u2013613","journal-title":"J Clin Oncol"},{"key":"720_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0165-4608(95)00084-4","volume":"84","author":"HF Tien","year":"1995","unstructured":"Tien HF, Wang CH, Lin MT et al (1995) Correlation of cytogenetic results with immunophenotype, genotype, clinical features and ras-mutation in acute myeloid leukemia. Cancer Genet Cytogenet 84:60\u201368. doi: 10.1016\/0165-4608(95) 00084-4","journal-title":"Cancer Genet Cytogenet"},{"key":"720_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.2870030102","volume":"3","author":"B Johansson","year":"1990","unstructured":"Johansson B, Mertenes F, Mitelman F (1990) Geographic heterogeneity of neoplasm-associated chromosome aberrations. Genes Chromosomes Cancer 3:1\u20137. doi: 10.1002\/gcc.2870030102","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"720_CR16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","volume":"24","author":"M Yanada","year":"2006","unstructured":"Yanada M, Takeuchi J, Sugiura I et al (2006) High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 24(3):460\u2013466. doi: 10.1200\/JCO.2005.03.2177","journal-title":"J Clin Oncol"},{"key":"720_CR17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/blood.V106.11.1830.1830","volume":"106","author":"DA Thomas","year":"2005","unstructured":"Thomas DA, Faderl S, Cortes J et al (2005) Outcome with the hyper-CVAD and imatinib mesylate regimen in Philadelphia (Ph) positive acute lymphocytic leukemia (ALL). Blood 106:1830 abstract","journal-title":"Blood"},{"key":"720_CR18","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V104.11.4483.4483","volume":"104","author":"JM Ribera","year":"2004","unstructured":"Ribera JM, Oriol A, Gonzalez M et al (2004) Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate. Blood 104:4483 abstract","journal-title":"Blood"},{"issue":"9","key":"720_CR19","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2006-10-052746","volume":"109","author":"M Vignetti","year":"2007","unstructured":"Vignetti M, Fazi P, Cimino G et al (2007) Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood 109(9):3676\u20133678. doi: 10.1182\/blood-2006-10-052746","journal-title":"Blood"},{"issue":"5","key":"720_CR20","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2005-11-4386","volume":"108","author":"B Wassmann","year":"2006","unstructured":"Wassmann B, Pfeifer H, Goekbuget N et al (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph-positive ALL). Blood 108(5):1469\u20131477. doi: 10.1182\/blood-2005-11-4386","journal-title":"Blood"},{"issue":"2","key":"720_CR21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107(2):76\u201394. doi: 10.1159\/000046636","journal-title":"Acta Haematol"},{"issue":"3\u20134","key":"720_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428190009148847","volume":"36","author":"S Faderl","year":"2000","unstructured":"Faderl S, Kantarjian HM, Thomas DA et al (2000) Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma 36(3\u20134):263\u2013273. doi: 10.3109\/10428190009148847","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"720_CR23","first-page":"119","volume":"40","author":"X Thomas","year":"1998","unstructured":"Thomas X, Thiebaut A, Olteanu N et al (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 40(3):119\u2013128","journal-title":"Hematol Cell Ther"},{"key":"720_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V77.5.1050.1050","volume":"77","author":"C Russo","year":"1991","unstructured":"Russo C, Carroll A, Kohler S et al (1991) Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 77:1050\u20131056","journal-title":"Blood"},{"issue":"5","key":"720_CR25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.leu.2403327","volume":"18","author":"NA Heerema","year":"2004","unstructured":"Heerema NA, Nachman JB, Sather HN et al (2004) Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group. Leukemia 18(5):939\u2013947. doi: 10.1038\/sj.leu.2403327","journal-title":"Leukemia"},{"issue":"10","key":"720_CR26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jmg.2008.058883","volume":"45","author":"K Buysse","year":"2008","unstructured":"Buysse K, Crepel A, Menten B et al (2008) Mapping of 5q35 chromosomal rearrangements within a genomically unstable region. J Med Genet 45(10):672\u2013678. doi: 10.1136\/jmg.2008.058883","journal-title":"J Med Genet"},{"issue":"1","key":"720_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0145-2126(00)00084-9","volume":"25","author":"S Faderl","year":"2001","unstructured":"Faderl S, Gidel C, Kantarjian HM et al (2001) Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia. Leuk Res 25(1):39\u201343. doi: 10.1016\/S0145-2126(00) 00084-9","journal-title":"Leuk Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0720-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0720-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0720-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:28:59Z","timestamp":1589635739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0720-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,10]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0720-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,10]]}}}